How an Unproven Alzheimer’s Drug Got Approved

Leave a Comment / Aduhelm (Drug), Alzheimer's Disease, Biogen Inc, Brain, Clinical Trials, Drugs (Pharmaceuticals), Elderly, Food and Drug Administration, Labeling and Labels (Product), Regulation and Deregulation of Industry, Research, Science and Technology, your-feed-healthcare, your-feed-science

How an Unproven Alzheimer’s Drug Got ApprovedThough some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab.http://rss.nytimes.com/services/xml/rss/nyt/Technology.xmlNYT > Technologyhttps://static01.nyt.com/images/misc/NYT_logo_rss_250x40.pngTechnology124Pam Belluck, Sheila Kaplan and Rebecca Robbins Powered by WPeMatico

How an Unproven Alzheimer’s Drug Got Approved Read More »